Ospedale Vito Fazzi Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT00846755
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Ospedale V. Fazzi

Active Ingredients

Drugs in Phase 2 Trials (2)

aprepitant (Emend) (1 trial)

palonosetron (aloxi) (1 trial)

Drugs in Other Trials (2)

levothyroxine (Synthroid) (1 trial)

propylthiouracil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Nausea (Phase 2)

Vomiting (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4